Fumiko Chino on Muck Rack

Fumiko Chino

Houston
As seen in: Color Research & Application, USA Today, Wiley Online Library, Yahoo Canada, Los Angeles Times, The Conversation, JAMA (The Journal of the American Medical Association), JAMA Network, JAMA Oncology, Salon and
#RadOnc. Reformed Artist. Cancer Widow. I study #FinancialToxicity #Access #Equity @MDAndersonNews 📲me COI bit.ly/3OBu0Cn
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fumiko

Contact Fumiko, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Composition by Sex of State and Federal Legislative Health Committees

|
By Daeun Sung, Michael Rooney, Reshma Jagsi, Fumiko Chino, Nancy D. Spector, Gita Suneja, Brielle Shorter, Angela Fagerlin, Kekoa Taparra, Bismarck C. Odei, Latifat Sulaimon, Mackenzie Nielson
| JAMA Network Verified
Composition by Sex of State and Federal Legislative Health Committees Introduction State and federal legislation shape US health policy, and much of this work occurs within legislative health care committees, where bills are introduced, amended, rejected, or advanced to the full chamber for debate and voting.1 Given these committees’ impact on policy priorities, understanding their demographic composition offers insight into potential influences on health policy decision-making.2-4 Methods...
Open in Who Shared Issue with article?

Joining Commercialization and Innovation to Bring New Cancer Therapies

|
By Roman Fabbricatore, Russ Conroy, Fumiko Chino
| ONCOLOGY journal Verified
In a conversation with CancerNetwork®, Vanessa Almendro-Navarro, PhD, MBA, who recently joined City of Hope as chief commercialization officer, discussed her background as a research fellow at Dana-Farber Cancer Institute, as well as how her clinical background will impact her new role. In describing her background as a fellow, she explained that Dana-Farber was one of the few institutions that pioneered research in intratumor heterogeneity, as well as breast cancer stem cell tumor evolution.
Open in Who Shared Issue with article?

Bridging the "Survivorship Cliff" After Radiotherapy for Breast Cancer

|
By Fumiko Chino, Saad Usmani, Ariana Pelosci Verified
| ONCOLOGY journal Verified
For many patients with cancer, the end of daily radiation therapy is a celebrated milestone. But for others, it can be daunting.
Open in Who Shared Issue with article?
See all 67 licensed articles (72 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified